{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T10:44:58Z","timestamp":1781347498456,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H02631"],"award-info":[{"award-number":["21H02631"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008529","name":"Chiba University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008529","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17nk0101358h0001"],"award-info":[{"award-number":["17nk0101358h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18nk0101358h0002"],"award-info":[{"award-number":["18nk0101358h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19nk0101358h0003"],"award-info":[{"award-number":["19nk0101358h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.biopha.2023.114405","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T23:40:12Z","timestamp":1676418012000},"page":"114405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["N-butyldeoxynojirimycin (miglustat) ameliorates pulmonary fibrosis through inhibition of nuclear translocation of Smad2\/3"],"prefix":"10.1016","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6328-9727","authenticated-orcid":false,"given":"Hiroyuki","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0168-4574","authenticated-orcid":false,"given":"Ayako","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eon","family":"Kurumiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9717-6763","authenticated-orcid":false,"given":"Risa","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyota","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitoshi","family":"Kasuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Takabatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7141-0088","authenticated-orcid":false,"given":"Takuya","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114405_bib1","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMcibr070490","article-title":"Idiopathic pulmonary fibrosis-new insights","volume":"356","author":"Verma","year":"2007","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2023.114405_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1476-5381.2011.01247.x","article-title":"Novel therapeutic approaches for pulmonary fibrosis","volume":"163","author":"Datta","year":"2011","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114405_bib3","first-page":"123","article-title":"Fibroblasts in fibrosis: novel roles and mediators","volume":"5","author":"Keddall","year":"2014","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2023.114405_bib4","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","article-title":"Recent developments in myofibroblast biology: paradigms for connective tissue remodeling","volume":"180","author":"Hinz","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2023.114405_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109861","article-title":"Role of sphingosine 1-phosphate signalling in tissue fibrosis","volume":"78","author":"Donati","year":"2021","journal-title":"Cell Signal"},{"key":"10.1016\/j.biopha.2023.114405_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jbior.2014.09.008","article-title":"Sphingolipids in pulmonary fibrosis","volume":"57","author":"Huang","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.biopha.2023.114405_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejphar.2012.09.038","article-title":"Contrary effects of sphingosine-1-phosphate on expression of \u03b1-smooth muscle actin in transforming growth factor \u03b21-stimulated lung fibroblasts","volume":"696","author":"Kawashima","year":"2012","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114405_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbrc.2015.07.159","article-title":"Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE-\/- mice","volume":"465","author":"Mishra","year":"2015","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2023.114405_bib9","doi-asserted-by":"crossref","first-page":"F204","DOI":"10.1152\/ajprenal.00150.2015","article-title":"Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells","volume":"309","author":"Subathra","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.biopha.2023.114405_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2021.108317","article-title":"An overview of therapeutic potential of N-alkylated 1-deoxynojirimycin congeners","volume":"504","author":"Iftikhar","year":"2021","journal-title":"Carbohydr. Res"},{"key":"10.1016\/j.biopha.2023.114405_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114405_bib12","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0960-9822(01)00396-7","article-title":"Critical role for glycosphingolipids in Niemann-Pick disease type C","volume":"11","author":"Zervas","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.biopha.2023.114405_bib13","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1039\/C7SC04712F","article-title":"Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones","volume":"9","author":"Pereira","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.biopha.2023.114405_bib14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fmolb.2020.00192","article-title":"Inhibition of the SET8 pathway ameliorates lung fibrosis even through fibroblast dedifferentiation","volume":"7","author":"Ugai","year":"2020","journal-title":"Front Mol. Biosci."},{"issue":"507\u2013511","key":"10.1016\/j.biopha.2023.114405_bib15","first-page":"514","article-title":"Standardized quantification of pulmonary fibrosis in histological samples","volume":"44","author":"H\u00fcbner","year":"2008","journal-title":"Biotechniques"},{"key":"10.1016\/j.biopha.2023.114405_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1165\/rcmb.2003-0063OC","article-title":"Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression","volume":"29","author":"Hu","year":"2003","journal-title":"Am. J. Cell Mol. Biol."},{"key":"10.1016\/j.biopha.2023.114405_bib17","doi-asserted-by":"crossref","first-page":"04855","DOI":"10.3892\/ijmm.2021.4857","article-title":"miR-106b-5p targeting SIX1 inhibits TGF-\u03b21-induced pulmonary fibrosis and epithelial-mesenchymal transition in asthma through regulation of E2F1","volume":"47","author":"Liu","year":"2021","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.biopha.2023.114405_bib18","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.bbamem.2006.08.017","article-title":"Inhibitors of sphingolipid metabolism enzymes","volume":"1758","author":"Delgado","year":"2006","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2023.114405_bib19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1254\/jphs.10181FP","article-title":"Activation of ceramidase and ceramide kinase by vanadate via a tyrosine kinase-mediated pathway","volume":"114","author":"Tada","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.114405_bib20","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1096\/fj.201601357R","article-title":"Antifibrotic effects of cyclosporine A on TGF-\u03b21-treated lung fibroblasts and lungs from bleomycin-treated mice: role of hypoxia-inducible factor-1\u03b1","volume":"31","author":"Yamazaki","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2023.114405_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jb\/mvv024","article-title":"Arkadia enhances BMP signalling through ubiquitylation and degradation of Smad6","volume":"158","author":"Tsubakihara","year":"2015","journal-title":"J. Biochem"},{"key":"10.1016\/j.biopha.2023.114405_bib22","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210777","article-title":"Arkadia-SKI\/SnoN signaling differentially regulates TGF-\u03b2-induced iTreg and Th17 cell differentiation","volume":"218","author":"Xu","year":"2021","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.biopha.2023.114405_bib23","article-title":"Research progress in the molecular mechanisms, therapeutic targets, and drug development of idiopathic pulmonary fibrosis","volume":"13","author":"Ma","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2023.114405_bib24","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1248\/bpb.25.1417","article-title":"Effect of Sho-saiko-to extract on hepatic inflammation and fibrosis in dimethylnitrosamine induced liver injury rats","volume":"25","author":"Kusunose","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.biopha.2023.114405_bib25","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1211\/0022357991773429","article-title":"Effects of Sho-saiko-to extract on liver fibrosis in relation to the changes in hydroxyproline and retinoid levels of the liver in rats","volume":"51","author":"Ono","year":"1999","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.biopha.2023.114405_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1211\/0022357001773599","article-title":"Effect of Sho-saiko-to extract on HGF and TGF-beta levels of intraorgans in liver-injured rats after partial hepatectomy","volume":"52","author":"Ono","year":"2000","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.biopha.2023.114405_bib27","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s40265-015-0468-9","article-title":"Eliglustat: A review in Gaucher disease type 1","volume":"75","author":"Scott","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2023.114405_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104763","article-title":"GBA2-encoded \u03b2-glucosidase activity is involved in the inflammatory response to Pseudomonas aeruginosa","volume":"9","author":"Loberto","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114405_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00058-21","article-title":"Iminosugar Glucosidase Inhibitors Reduce Hepatic Inflammation in Hepatitis A Virus-Infected Ifnar1-\/-Mice","volume":"95","author":"Misumi","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2023.114405_bib30","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1074\/jbc.M114.579532","article-title":"Novel regulation of Ski protein stability and endosomal sorting by actin cytoskeleton dynamics in hepatocytes","volume":"290","author":"V\u00e1zquez-Victorio","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114405_bib31","doi-asserted-by":"crossref","first-page":"H75","DOI":"10.1152\/ajpheart.00453.2014","article-title":"SnoN as a novel negative regulator of TGF-\u03b2\/Smad signaling: a target for tailoring organ fibrosis","volume":"308","author":"Zeglinski","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2023.114405_bib32","doi-asserted-by":"crossref","first-page":"20492","DOI":"10.1074\/jbc.M701294200","article-title":"Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling","volume":"282","author":"Nagano","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114405_bib33","doi-asserted-by":"crossref","first-page":"F996","DOI":"10.1152\/ajprenal.00657.2013","article-title":"Increasing cGMP-dependent protein kinase activity attenuates unilateral ureteral obstruction-induced renal fibrosis","volume":"1","author":"Cui","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.biopha.2023.114405_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/CIRCRESAHA.107.170217","article-title":"Cyclic GMP\/protein kinase G phosphorylation of Smad3 blocks transforming growth factor-beta-induced nuclear Smad translocation: a key antifibrogenic mechanism of atrial natriuretic peptide","volume":"102","author":"Buxton","year":"2008","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2023.114405_bib35","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1210\/me.2011-1009","article-title":"cGMP inhibits TGF-beta signaling by sequestering Smad3 with cytosolic beta2-tubulin in pulmonary artery smooth muscle cells","volume":"25","author":"Gong","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.biopha.2023.114405_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejphar.2008.03.015","article-title":"Isoliquiritigenin, a flavonoid from licorice, relaxes guinea-pig tracheal smooth muscle in vitro and in vivo: role of cGMP\/PKG pathway","volume":"587","author":"Liu","year":"2008","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114405_bib37","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.RES.0000191538.76771.66","article-title":"Nitric oxide regulates transforming growth factor-beta signaling in endothelial cells","volume":"97","author":"Saura","year":"2005","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2023.114405_bib38","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.2337\/db19-0049","article-title":"The Iminosugar AMP-DNM Improves Satiety and Activates Brown Adipose Tissue Through GLP1","volume":"68","author":"Herrera Moro Chao","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2023.114405_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1085\/jgp.201611637","article-title":"Extraoral bitter taste receptors in health and disease","volume":"149","author":"Lu","year":"2017","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.biopha.2023.114405_bib40","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1513\/AnnalsATS.201410-448MG","article-title":"Mechanisms of alveolar epithelial injury, repair, and fibrosis","volume":"Suppl 1","author":"Chambers","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.biopha.2023.114405_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1183\/09059180.00001111","article-title":"Antifibrotic activities of pirfenidone in animal models","volume":"20","author":"Schaefer","year":"2011","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.biopha.2023.114405_bib42","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2023.114405_bib43","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/annrheumdis-2014-207109","article-title":"Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis","volume":"75","author":"Huang","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2023.114405_bib44","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1167\/iovs.08-2815","article-title":"Effects of pirfenidone on proliferation, migration, and collagen contraction of human Tenon's fibroblasts in vitro","volume":"50","author":"Lin","year":"2009","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2023.114405_bib45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1165\/rcmb.2014-0445OC","article-title":"Novel mechanisms for the antifibrotic action of nintedanib","volume":"54","author":"Rangarajan","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.biopha.2023.114405_bib46","doi-asserted-by":"crossref","first-page":"1800230","DOI":"10.1183\/13993003.00230-2018","article-title":"Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis","volume":"52","author":"Flaherty","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2023.114405_bib47","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.resinv.2021.04.005","volume":"59","author":"Hisata","year":"2021","journal-title":"Respir. Invest."},{"key":"10.1016\/j.biopha.2023.114405_bib48","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1183\/09031936.00198013","article-title":"Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis","volume":"45","author":"Ogura","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2023.114405_bib49","doi-asserted-by":"crossref","first-page":"1801060","DOI":"10.1183\/13993003.01060-2018","article-title":"No relevant pharmacokinetic drug-drug interaction between nintedanib and pirfenidone","volume":"53","author":"Richeldi","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2023.114405_bib50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.201706-1301OC","article-title":"INJOURNEY Trial Investigators. Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial","volume":"197","author":"Vancheri","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.biopha.2023.114405_bib51","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12890-019-0920-9","article-title":"Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer\/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: a case report","volume":"19","author":"Yamakawa","year":"2019","journal-title":"BMC Pulm. Med"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223001932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223001932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:54:43Z","timestamp":1776772483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223001932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":51,"alternative-id":["S0753332223001932"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114405","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-butyldeoxynojirimycin (miglustat) ameliorates pulmonary fibrosis through inhibition of nuclear translocation of Smad2\/3","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114405"}}